Latest news and articles about Henrui Medicine
Total: 1 articles found
China’s pharmaceutical sector is reaching a critical milestone as the first entirely AI-designed drug enters Phase III trials for pulmonary fibrosis, while domestic giants like Henrui Medicine aggressively challenge the global weight-loss drug duopoly. These developments, supported by record-breaking international licensing deals, mark China's transition from a fast-follower to a primary innovator in global drug development.
